The maladaptive effects of HIV protease inhibitors (lopinavir/ritonavir) on the rat heart

被引：9
|
作者：
Reyskens, Kathleen M. S. E. [1 ]
Essop, M. Faadiel [1 ]
机构：
[1] Univ Stellenbosch, CMRG, Dept Physiol Sci, ZA-7600 Stellenbosch, South Africa
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2013年 / 168卷 / 03期
基金：
新加坡国家研究基金会;
关键词：
HIV-AIDS; HIV protease inhibitors; Cardiovascular diseases; Ischemia-reperfusion; Metabolism;
D O I：
10.1016/j.ijcard.2013.04.128
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：3047 / 3049
页数：4
相关论文
共 50 条
  • [1] The Maladaptive Effects of HIV Protease Inhibitors (Lopinavir/Ritonavir) on the Rat Heart
    Reyskens, Kathleen M. S. E.
    Fisher, Tarryn-Lee
    Schisler, Jonathan C.
    O'Connor, Wendi G.
    Rogers, Arlin B.
    Willis, Monte S.
    Planesse, Cynthia
    Rondeau, Philippe
    Bourdon, Emmanuel
    Essop, M. Faadiel
    PLOS ONE, 2013, 8 (09):
  • [2] Effects of NO-Hybridization on the Immunomodulatory Properties of the HIV Protease Inhibitors Lopinavir and Ritonavir
    Fagone, Paolo
    Mangano, Katia
    Quattrocchi, Cinzia
    Cavalli, Eugenio
    Mammana, Santa
    Lombardo, Giuseppe A. G.
    Pennisi, Vincenzo
    Zocca, Mai-Britt
    He, Mingzhu
    Al-Abed, Yousef
    Nicoletti, Ferdinando
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 117 (05) : 306 - 315
  • [3] The effect of the HIV protease Inhibitors indinavir and lopinavir/ritonavir on thrombolytic factors
    Lee, G. A.
    ANTIVIRAL THERAPY, 2006, 11 (07) : L63 - L63
  • [4] The effects of HIV protease inhibitors atazanavir and lopinavir/ritonavir on insulin sensitivity in HIV-seronegative healthy adults
    Noor, MA
    Parker, RA
    O'Mara, E
    Grasela, DM
    Currie, A
    Hodder, SL
    Fiedorek, FT
    Haas, DW
    AIDS, 2004, 18 (16) : 2137 - 2144
  • [5] Lopinavir/ritonavir: a protease inhibitor for HIV-1 treatment
    Barragan, Patricia
    Podzamczer, Daniel
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (13) : 2363 - 2375
  • [6] Effects of antiretroviral protease inhibitors, lopinavir and ritonavir, on the hepatobiliary disposition of bile acids in sandwich-cultured rat hepatocytes
    Griffin, LaToya M.
    Brouwer, Kim L. R.
    DRUG METABOLISM REVIEWS, 2011, 43 : 197 - 197
  • [7] Farnesyltransferase inhibitors prevent HIV protease inhibitor (lopinavir/ritonavir)-induced lipodystrophy and metabolic syndrome in mice
    Tanaka, Tomokazu
    Nakazawa, Harumasa
    Kuriyama, Naohide
    Kaneki, Masao
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (02) : 1314 - 1320
  • [8] Lopinavir plus ritonavir: a novel protease inhibitor combination for HIV infections
    Tan, Darrell
    Walmsley, Sharon
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2007, 5 (01) : 13 - 28
  • [9] Kaletra - Lopinavir/ritonavir capsules, oral solution - Abbott - Combination of new and existing protease inhibitors for Tx of HIV
    不详
    FORMULARY, 2000, 35 (11) : 867 - 867
  • [10] Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir
    McCance-Katz, Elinore F.
    Moody, David E.
    Smith, Patrick F.
    Morse, Gene D.
    Friedland, Gerald
    Pade, Patricia
    Baker, Jennifer
    Alvanzo, Anika
    Jatlow, Peter
    Rainey, Petrie M.
    CLINICAL INFECTIOUS DISEASES, 2006, 43 : S235 - S246
12345